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Greenhalgh and colleagues argue in their recent BMJ analysis piece that policymakers should 
encourage the public to wear face masks, as the Covid-19 crisis continues to deepen.1 The evidence 
for such a measure, they acknowledge, remains sparse. Two systematic reviews—both currently 
unreviewed preprints—conclude that “the evidence is not sufficiently strong to support widespread 
use of facemasks as a protective measure against COVID19,”2 and that “masks alone have no 
significant effect in interrupting spread of [influenza-like illnesses …] or influenza.”3 Another preprint 
review, with more opaque methods but encompassing an eclectic range of disciplinary perspectives, 
is more positive, recommending “adoption of public cloth mask wearing, as an effective form of source 
control, in conjunction with existing hygiene, distancing, and contact tracing strategies.”4 With the lead 
author of this review, Greenhalgh has written a public-facing summary of the evidence, concluding 
that “assessment of this evidence leads us to a clear conclusion: keep your droplets to yourself – 
wear a mask.”5 
In the absence of a clear consensus on the value or otherwise of wearing face masks in community 
settings, Greenhalgh et al. invoke the precautionary principle. While the uncertainties may be real, 
they suggest, enough evidence exists to suggest plausible, if not probable, benefit—and equally 
importantly, that the downsides are either negligible or improbable.1 With roots in the social scientific 
literature on science and innovation policy, the precautionary principle is usually used to advise 
caution in the uptake of innovations with known benefits but uncertain or unmeasurable downsides, 
for example through restrictive regulation.6,7 Examples include the 1992 Rio Declaration on 
Environment and Development, the 2002 Cartagena Protocol on Biosafety, and a wide range of 
national efforts to control individuals’ exposure to radiation.8 Greenhalgh et al. approach the question 
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from the opposite angle: that the risks of not acting are great, that the risks of acting are minimal and 
the potential benefits strong, and so action is imperative. They offer four sets of possible counter-
arguments: the lack of evidence of effectiveness; the risk of poor adherence and thus reduced 
effectiveness; the potential for ‘risk compensation’9 (whereby mask-wearers, feeling safer, fail to 
observe other measures, such as hand hygiene or social distancing); and the potential impact on 
mask supplies, particularly for healthcare workers. Given the unprecedented circumstances of the 
outbreak, they suggest that these arguments are either invalid, or outweighed by the likely upsides. 
We agree with Greenhalgh and colleagues that rapid translation of scientific knowledge into policy 
and practice is vital in a time of crisis. We also acknowledge that the likelihood of a definitive scientific 
evidence base on this topic is vanishingly small, given not only the timeframes, but also the 
methodological challenges posed by the subject, and its inherently multidisciplinary nature. However, 
we believe that the potential downsides of a policy shift towards the mass adoption of face masks 
deserve a greater airing. Correspondingly, we urge restraint in communication to both policymakers 
and the public on the subject—and suggest that the current crisis makes caution in science 
communication more important, not less. 
Mass uptake of face masks in community settings: the possible downsides 
Crudely, the case against a shift in policy might be made at five levels: the weaknesses in the 
evidence base for adoption of face masks in community settings; potential unintended consequences 
at individual level; potential unintended consequences at the microsocial level; potential unintended 
consequences at the macrosocial level; and the unknown and difficult-to-anticipate consequences of 
introducing a complex intervention. We briefly discuss each in turn. 
First, the very weak evidence for face masks should be reiterated. Although some important studies 
followed the outbreak of SARS-Cov-1 in the 2000s, by and large the quality and clarity of the 
evidence base for face masks as a means of reducing transmission is disappointing. Few studies 
examine use of face masks in community settings; those that do find no evidence of reduced 
transmission compared with no face masks.3 Observational studies of face mask usage are, as one 
might expect, heavily confounded by the parallel implementation of other measures such as social 
distancing and isolation; experimental studies are limited by the impossibility of blinding and thus 
weak adherence in intervention and control groups.2 Of course, absence of evidence is not evidence 
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of absence, and both recent systematic reviews cautiously suggest that in some circumstances, 
wearing of face masks may be warranted (in “community settings where contact may be casual and 
relatively brief,”2 and in clinical settings3). But existing research also provides little information on 
potential harms, such as “discomfort, dehydration, facial dermatitis, distress, headaches, 
exhaustion.”3 Here, too, absence of evidence should not be taken as evidence of absence. 
Second, it is unclear how well equipped the general public is to make proper use of face masks, or 
how readily good practice might be disseminated and taken up. Appropriate use of face masks is 
challenging and is something healthcare workers themselves can struggle with;10 poor use (including 
poor fitting, adjustment, touching) can reduce effectiveness and pose an infection risk in itself. Used 
disposable face masks must be removed and discarded properly because they accumulate 
pathogens;11 inappropriately discarded masks present an infection risk. For non-disposable cloth-
based masks, the evidence base is slim, though one hospital-based three-arm trial found worse 
infection outcomes in wearers of cloth masks than in wearers of medical masks and in a control group 
(usual practice, which included much mask-wearing).12 Cloth masks will retain moisture, with 
indeterminate consequences for their efficacy and for the creation of a microbiological environment 
favourable to other bacterial or viral organisms. Greenhalgh and Howard advocate homemade masks 
fashioned from a “t-shirt, handkerchief, or paper towel, or […] a scarf or bandana around your face,” 
ideally using “tightly woven fabric” and “including a layer of paper towel as a disposable filter.”5 The 
availability of time, space and materials to prepare, don and properly disinfect a homemade face 
mask is likely to vary markedly by socio-economic and other demographic characteristics. An 
evidence base for homemade masks is likely to be elusive. However, the existing research, coupled 
with the potential for great variation in materials, fit, adherence, touching and adjustment, doffing, 
disposal, frequency of laundering and so on, suggests the need for caution in advising widespread 
uptake, especially given the paucity of evidence for cloth face masks, their use, and their possible 
microbiological downsides. 
Third, at the microsocial level, the argument might be made that encouraging uptake of face masks 
might lead to reduced compliance with other measures, due to the false sense of security presented 
by the mask. Such arguments rest on evidence around risk compensation in other areas of public 
health, for example seatbelts,13 cycle helmets,14 vaccination against sexually transmitted infections,15 
and injury prevention in competitive sports.16 The evidence base in these fields is inconsistent, with 
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some studies finding evidence of risk compensation (including risks to self and risks to others), and 
others finding no effect.9 Moreover, its transferability to the case of face masks is not self-evident, 
given the unprecedented nature of the Covid-19 crisis, and the fact that these interventions are 
primarily oriented towards the safety of the individual, whereas the case made by Greenhalgh and 
colleagues is premised on protecting public health. Nevertheless, there is a case that face masks 
might promote, if not active risk-taking, then at least a complacency that might reduce adherence to 
other measures, especially given the largely collective rather than individual benefits that the wearing 
of masks seeks to address. Such complacency might be mitigated by the more selective use of face 
masks in certain higher-risk environments suggested by Brainard et al.,2 which might do more to 
maintain their additive role and the importance of proper use. There is also an argument that universal 
mask-wearing might aggravate the climate of fear already documented for Covid-19,17 adding to 
mental health concerns by providing a constant reminder of the threat posed by other humans.  
Fourth, potential downsides of the promotion of face masks in community settings present themselves 
at the macrosocial level. Greenhalgh et al. acknowledge that wider uptake of masks might result in 
greater pressure on supply chains for healthcare workers, but argue that the proper response is to 
produce more masks.1 Given the likely sustained demand for masks, however, and in light of the 
difficulty of procuring appropriate personal protective equipment for healthcare workers in the UK and 
elsewhere,18 the ease with which such a call can be answered is questionable. Homemade cloth 
masks, Greenhalgh et al. suggest, might offer an interim solution, but if they prove ineffective or even 
turn out to be associated with negative outcomes, a rush to obtain equipment intended for use by 
healthcare workers is conceivable. The likely consequences for healthcare staff in such a scenario 
are stark. It has the potential to exacerbate health inequalities too—both within countries and 
internationally, with disparities in nations’ ability to access supplies crucial in the response to 
Coronavirus already apparent, along achingly familiar lines.19 The sociological dynamics of 
widespread mask adoption are also difficult to anticipate but potentially adverse, particularly if 
encouragement to wear masks evolved into more coercive measures (as suggested by Greenhalgh 
and Howard5). As a highly visible symbol of virtuous behaviour, those who fail to comply—for 
example, because of respiratory ailments that make prolonged mask-wearing dangerous,20 or 
because of religious preferences such as beards worn by Sikh men or hijabs worn by Muslim women 
that may make mask-wearing difficult—may be subject to stigmatisation or worse. Even a permissive 
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policy risks ‘gold-plating’, where over-compliance in particular settings effectively imposes a universal 
rule.21 Meanwhile, notwithstanding the weak evidence base for face masks as a standalone measure, 
businesses or states might see widespread or mandatory mask-wearing as a warrant for a premature 
return to ‘business as usual’, justifying unsafe workplaces or crowded commuting conditions in terms 
of the protection offered by masks. 
This leads us to our final point. The consequences of a public health intervention of this nature—
particularly, though not only, if legally mandated—are by their nature difficult to anticipate. Face 
masks (and measures to secure their uptake) are a complex intervention in a complex system: the 
results of a change of this nature are emergent, unpredictable, and potentially counterintuitive.22,23 
The nature of complex systems is such that the outcomes of intervention are never fully amenable to 
either prediction or evaluation, but it is nevertheless crucial to give due consideration to the harms 
that might accrue24—and to monitor the system’s response and adapt accordingly.25 Given the 
bluntness of national and international policy as a mode of action, such adaptation may prove very 
challenging once a decision is made. 
Evidence and policy in unusual times 
To adopt an increasingly hackneyed turn of phrase, the challenges facing the world during the Covid-
19 epidemic are unprecedented. The need for action is urgent, and so both demand for, and supply 
of, evidence-informed policy recommendations has increased sharply. Researchers and policymakers 
face a common challenge: what to do in the face of competing forms of expertise, inconclusive 
evidence, and timelines that preclude the development of a more adequate evidence base? 
A definitive verdict on the circumstances in which face masks are most suitable is unlikely not only for 
these reasons, but also because evidence will necessarily be premised on value judgements, implicit 
or explicit. Rather than awaiting a consensus that will never arrive, it is incumbent upon researchers 
to engage with policymakers and the wider public to communicate science, inform public debate and 
increase the salience of evidence to policy decisions. However, in such engagement work it is also 
essential to be clear about the doubts, nuances and debates that remain. In their lay summary of the 
evidence around use of face masks in community settings, Greenhalgh and Howard declare that “the 
science says yes.”5 Their principal sources are Greenhalgh et al.’s analysis piece and Howard et al.’s 
literature review.1,4 At the time of writing, the Howard paper has not been subject to peer review. It is 
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not a systematic review, and its two-sentence description of methods states that “a community-driven 
approach was used for building the paper list used.”4 The potential for bias in such an approach is 
self-evident. Meanwhile—again at the time of writing—the WHO’s guidance remains that use of face 
masks in community settings is not warranted,11 though of course this position is subject to review 
and change, as science advances and self-corrects. 
Professor Greenhalgh’s work during the Covid-19 crisis exemplifies engaged academia, marshalling 
diverse resources to co-produce high-quality evidence in response to pressing questions from 
policymakers and practitioners. Such engaged academic work, though, brings challenges.26 On this 
occasion, we believe public-facing communications regarding the scientific view on the balance of 
risks and benefits of widespread uptake of face masks have exceeded the scientific evidence base.  
Efforts to communicate a position so strongly in favour of widespread use of masks in the community, 
against current WHO advice and in the face of persistent evidence gaps and debates, risk promoting 
policy that is based more on eminence—the track record, credentials and status of the authors—than 
on evidence. High-quality science communication involves communicating uncertainty as well as 
recommendation.27 The unintended consequences of unequivocal advocacy of a contested position 
go beyond the downsides of policy implementation: they include the potential erosion of trust in 
science as a field in general, when the measures put forward by science fail to live up to their 
promise, or result in problems that could be or had been anticipated. 
We endorse Greenhalgh et al.’s call for more research on the use of face masks, and agree that 
useful knowledge is much more likely to arise from ecological studies, ‘natural experiments’ and other 
uncontrolled and non-experimental study designs. However, in the meantime, we urge adherence to 
the precautionary principle in science communication, given the risks that well-meaning action entails. 
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